期刊文献+

稳定转染PTEN基因后对卵巢上皮性癌细胞磷酸酰肌醇3激酶/蛋白激酶B信号传导通路的影响 被引量:2

Effects of PTEN over-expression on phosphatidyl inositol 3-kinase/protein kinase B signal pathway in ovarian epithelial cancer cells
原文传递
导出
摘要 目的 研究外源性PTEN基因稳定转染卵巢上皮性癌(卵巢癌)细胞后,对卵巢癌细胞磷酸酰肌醇3激酶(PI3K)/蛋白激酶B(Akt)信号传导通路的影响.方法 构建表达野生型PTEN基因的重组载体pcDNA3.1A-PTEN质粒,并转染卵巢癌细胞株HO-8910细胞(重组载体组),以转染空载体pcDNA3.1A质粒(空载体组)作为阴性对照,以未转染质粒(空白组)作为空白对照.采用逆转录(RT)PCR技术检测3组细胞中PTEN、Akt1、Akt2、PI3K mRNA的表达水平,蛋白印迹法检测3组细胞中PTEN蛋白的表达强度,四甲基偶氮唑蓝(MTT)比色法检测3组细胞的生长情况[以吸光度(A)值表示,A值越大表示生长速度越快].结果 表达野生型PTEN基因的重组载体pcDNA3.1A-PTEN质粒,经测序证实构建成功.重组载体组细胞中PTEN mRNA的表达水平为(17372±23)copy/ml,高于空载体、空白组[分别为(39±1)、(78±4)copy/ml],差异均有统计学意义(P<0.05);重组载体组细胞中PTEN蛋白的表达强度也明显高于空载体、空白组.重组载体组细胞中Akt1、Akt2、PI3KmRNA的表达水平分别为(28±2)、(7±1)、(61±2)copy/ml,低于空载体[分别为(115±5)、(18±2)、(84±2)copy/ml]、空白组[分别为(77±4)、(17±2)、(1349±7)copy/m1],差异均有统计学意义(P<0.05).培养第5天,重组载体组细胞生长速度(A值)为90 158±47,低于空载体、空白组(分别为148 251±65、250 115±62),差异均有统计学意义(P<0.05).结论 转染表达野生型PTEN基因的重组载体能有效提高卵巢癌HO-8910细胞中PTEN mRNA和蛋白的表达,抑制细胞生长,并通过显著降低Akt1、Akt2、PI3K mRNA的表达水平,明显抑制PI3K/Akt信号传导通路. Objective To evaluate the effect of exogenous wild PTEN gene stable transfected into human ovarian cancer cell line HO-8910 on phosphatidyl inositol 3-kinase( PI3K)/protein kinase B (Akt)siganal pathway and cells proliferation. Methods Wild-type PTEN recombinant eukaryotic expression plasmid was constructed and then was transfected into HO-8910 cells by lipofectamine 2000. The expression of PTEN, Akt1, Akt2, PI3K mRNA and protein of PTEN were tested by reverse transcription( RT)-PCR and Western blot. The proliferation of HO-8910 after wild PTEN gene transfected was measured by methyl thiazolyl tetrazolium(MTT). Results Wild-type PTEN gene was successfully transfected into HO-8910 cells. The results of RT-PCR and western bolt showed that there were the significant expression high level of PTEN mRNA and protein after infected by wild-PTEN plasmid than those in the control[ ( 17 372 ±23)vs.(39±1 )vs. (78 ±4)copies/ml,P 〈0. 05 ]. While the expression of mRNA of Akt1, Akt2 and PI3K were decreased clearly than those in the control [ (28 ± 2 ) vs. ( 115 ± 5 ), (7 ± 1 ) vs. ( 18 ± 2), (61 ± 2 ) vs.(84 ± 2)copies/ml , all P 〈 0. 05 ]. The proliferation rate of HO-8910 cells was obviously slower than those in the control (90 158 ±47 vs. 148 251 ±65 vs. 250 115 ±62, P〈0.05). Conclusion Transfection of PTEN may increase the expression of PTEN and inhibit the proliferation of HO-8910 cells, in which PI3K/ Akt siganal pathway is inhibit significantly.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2010年第9期682-685,共4页 Chinese Journal of Obstetrics and Gynecology
基金 基金项目:南京医科大学科技发展基金重点项目(2005NYDZD23)
关键词 卵巢肿瘤 PTEN磷酸水解酶 1-磷脂酰肌醇3-激酶 原癌基因蛋白质c-akt 信号传导 Ovarian neoplasms PTEN phosphohydrolase 1-Phosphatidylinositol 3-kinase Proto-oncogene proteins c-akt Signal transduction
  • 相关文献

参考文献4

  • 1Parsons R.Human cancer,PTEN and the PI-3 kinase pathway.Semin Cell Dev Biol,2004,15:171-176.
  • 2黄秀兰,崔国辉,周克元.PI3K-Akt信号通路与肿瘤细胞凋亡关系的研究进展[J].癌症,2008,27(3):331-336. 被引量:118
  • 3Hartmann W,Digon-S(o)ntgerath B,Koch A,et al.Phosphatidylinositol 3'-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN.Clin Cancer Res,2006,12:3019-3027.
  • 4Osaki M,Oshimura M,Ito H.PI3K-Akt pathway:its functions and alterations in human cancer.Apoptosis,2004,9:667-676.

二级参考文献58

  • 1康春生,浦佩玉,李捷,王广秀.反义及显性负调节AKT2 RNA对脑胶质瘤细胞增殖抑制作用的体外研究[J].癌症,2004,23(11):1267-1272. 被引量:5
  • 2王宏梅,陈龙华,郑小康,李启生,伍新尧,夏云飞.抑制ATM/PI3K功能区表达对鼻咽癌细胞CNE1辐射增敏的研究[J].癌症,2006,25(9):1097-1101. 被引量:9
  • 3Atkins M B, Hidalgo M, Stadler W M, et al. Randomized phase Ⅱ study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma [J]. J Clin Oncol, 2004, 22(5) :909-918.
  • 4Christian T, James R, Zoran F, et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer : implications for therapy [ J ]. Proc Natl Acad Sci USA, 2006,103 (6) : 1888-1893.
  • 5Adachi S, Leoni L M, Carson D A, et al. Apoptosis induced by molecular targeting therapy in hematological malignancies [J]. Acta Haematol, 2004,111(1-2) : 107-123.
  • 6Campiglio M, Olgiati C, Normanno N, et al. Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ( 'Iressa' ) is independent of EGFR expression level [J]. J Cell Physiol, 2004,198(2): 259-268.
  • 7Zhang M, Fang X, Liu H, et al. Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chIoro-2-methylellipticinium acetate (CMEP) [J]. Biochem Pharmacol, 2007,73( 1 ) : 15-24.
  • 8Douglas A L, Faina B, Cindy J Y, et al. Frequent mutation of the P1K3CA gene in ovarian and breast cancer [J]. Clin Cancer Res, 2005,11 (8):2875- 2878.
  • 9Knobbe C B, Kieslich A T, Reifenberger G. Genetic alteration and expression of the phosphoinositol-3- kinase/Akt pathway genes P1K3CA and PIKE in human glioblastomas [J]. Neuropathol Appl Neurobiol, 2005, 31 (5) :486-490.
  • 10Oda K, Stokoe D, Taketani Y, et al. High frequency of coexistent mutations of P1K3CA and PTEN genes in endometrial carcinoma [ R ]. Cancer Res, 2005,65(23) : 10669-10673.

共引文献117

同被引文献25

  • 1沈文洁,邢福祺,鲁永鲜,孔令红.印迹基因LOT1在卵巢上皮性癌组织中的表达及其甲基化的研究[J].中华妇产科杂志,2007,42(5):339-340. 被引量:2
  • 2刘彤华,李维华,廖松林.乳腺及女性生殖器官肿瘤病理学和遗传学(世界卫生组织肿瘤分类及诊断标准系列)[M].北京:人民卫生出版社,2006.119-123.
  • 3王莉,惠宁,满晓波,唐亮.GPC3在卵巢癌中的表达及其临床意义[J].解放军医学杂志,2007,32(10):1017-1019. 被引量:3
  • 4Jemal A, Siegel R, Ward E, et al.Cancer statistics,2009[J]. CA Cancer J CIin, 2009,59 : 225-249.
  • 5Tortes J, Pulido R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to preteasome mediated degradation[J].J Biol Chem, 2001,276 ( 2 ) : 993-998.
  • 6Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas[M].Am J Pathol, 2001,158 ( 6 ) : 2097-2106.
  • 7De GraeffP, Crijns AP, Ten Hoor KA, et al.The ErbB signaling pathway: protein expression and prognostic valve in epithelial ovarian cancer[J].Br J Ccncer, 2008,99 ( 2 ) : 341-349.
  • 8Andejlkovic T, Bankovic J, Stojsic J, et al.Coaherations of p53 and FFEN tumor suppressor genes in non-small cell lung carcinoma patients[J].Transl Res, 2011,157 ( 1 ) : 19-28.
  • 9Li J, Yen C, Liaw D, et al.PTEN, a putiative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[J].Chinclin Tumor, 2004,31( 7 ) : 365-367.
  • 10韩吉华,廖飞,邵佳琳,等.PTEN与mieroRNAs在肿瘤中的调节网络及作用[J].中华临床医师杂志(电子版),2013,20:9296-9299.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部